88425-71-2 Usage
Uses
Used in Agricultural Industry:
(2-methoxy-4-propylphenoxy)acetic acid is used as an herbicide for controlling various weed species. It works by disrupting the growth process of plants, inhibiting the production of essential proteins and enzymes.
Used in Industrial Settings:
(2-methoxy-4-propylphenoxy)acetic acid is used in industrial settings to manage unwanted vegetation. It is effective in controlling a wide variety of weed species and helps maintain clean and safe industrial areas.
Potential Pharmaceutical Applications:
(2-methoxy-4-propylphenoxy)acetic acid is also under study for potential pharmaceutical applications. Its unique molecular structure and properties may offer new opportunities for drug development and therapeutic interventions.
Safety Precautions:
It is important to handle (2-methoxy-4-propylphenoxy)acetic acid with care, as it can be harmful to humans and the environment if not used properly. Proper safety measures and guidelines should be followed to minimize any potential risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 88425-71-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,4,2 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 88425-71:
(7*8)+(6*8)+(5*4)+(4*2)+(3*5)+(2*7)+(1*1)=162
162 % 10 = 2
So 88425-71-2 is a valid CAS Registry Number.
88425-71-2Relevant articles and documents
Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating α-asarone-based HMG-CoA reductase inhibitors
Argueelles, Nancy,Sanchez-Sandoval, Eugenia,Mendieta, Aaron,Villa-Tanaca, Lourdes,Garduno-Siciliano, Leticia,Jimenez, Fabiola,Cruz, Maria del Carmen,Medina-Franco, Jose L.,Chamorro-Cevallos, German,Tamariz, Joaquin
experimental part, p. 4238 - 4248 (2010/09/12)
A series of α-asarone-based analogues was designed by conducting docking experiments with published crystal structures of human HMG-CoA reductase. Indeed, synthesis and evaluation of this series showed a highly hypocholesterolemic in vivo activity in a murine model, as predicted by previous docking studies. In agreement with this model, the polar groups attached to the benzene ring could play a key role in the enzyme binding and probably also in its biological activity, mimicking the HMG-moiety of the natural substrate. The hypolipidemic action mechanism of these compounds was investigated by developing a simple, efficient, and novel model for determining HMG-CoA reductase inhibition. The partial purification of the enzyme from Schizosaccharomyces pombe allowed for testing of α-asarone- and fibrate-based analogues, resulting in positive and significant inhibitory activity.
